EUVIMEDEUVIMED entdecken
Crossref

A LC–MS/MS method for the simultaneous determination of 6‐cyanodopamine, 6‐nitrodopamine, 6‐nitrodopa, 6‐nitroadrenaline and 6‐bromodopamine in human plasma and its clinical application in patients with chronic kidney disease

Luiz Fernando Ribeiro iD, Tainah Babadopulos, Mariana G de Oliveira, Flávio Nishimaru, Roberto Zatz, Rosilene Motta Elias, Odorico Moraes, Elisabete Moraes, Larryn W Peterson iD, Gilberto De Nucci

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Luiz Fernando Ribeiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Limit of Detection, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: São Paulo Research Foundation (FAPESP), National Science Foundation (NSF), National Council for Scientific and Technological Development (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to develop a high‐performance liquid chromatography–tandem mass spectrometry method for the determination of 6‐cyanodopamine, 6‐nitrodopamine, 6‐nitrodopa, 6‐nitroadrenaline and 6‐bromodopamine in human plasma samples. Strata‐X 33 μm solid‐phase extraction cartridges were used for the extraction of the catecholamines from human plasma samples. The catecholamines were separated in a 150 × 3 mm Shim‐pack GIST C 18 ‐AQ column with 3 μm particle size, placed in an oven at 40°C and perfused with 82% mobile phase A (acetonitrile–H 2 O; 90:10, v/v) + 0.4% acetic acid and 18% mobile phase B (deionized H 2 O) + 0.2% formic acid at a flow rate of 340 μl/min in isocratic mode. The injected volume was 4 μl and the run lasted 4 min. The method was linear from 0.1 to 20 ng/ml and the lower limit of quantification was 0.1 ng/ml for all analytes. The method was applied to evaluate the plasma levels of catecholamines in plasma of patients with chronic kidney disease and allowed the detection for the first time of circulating levels of the novel catecholamines 6‐bromodopamine and 6‐cyanodopamine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLimit of DetectionRenal Insufficiency, ChronicHumansReproducibility of ResultsLinear ModelsChromatography, High Pressure LiquidMaleChromatography, LiquidSolid Phase ExtractionDopamineCatecholaminesMiddle AgedLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

LC–MS/MShuman plasmanovel catecholaminessolid‐phase extraction

Substanzen

DopamineCatecholamines

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil.
  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Nephrology Center of Campinas, Campinas, SP, Brazil.
  • Clinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceará, Fortaleza, CE, Brazil.
  • Department of Chemistry, Rhodes College, Memphis, Tennessee, USA.
  • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.

ORCID-Profile: Luiz Fernando Ribeiro, Larryn W Peterson

Förderung

  • São Paulo Research Foundation (FAPESP)
  • National Science Foundation (NSF)
  • National Council for Scientific and Technological Development (CNPq)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Ribeiro, L. F., Babadopulos, T., de Oliveira, M. G., Nishimaru, F., Zatz, R., Elias, R. M., Moraes, O., Moraes, E., Peterson, L. W., & De Nucci, G. (2024). A LC–MS/MS method for the simultaneous determination of 6‐cyanodopamine, 6‐nitrodopamine, 6‐nitrodopa, 6‐nitroadrenaline and 6‐bromodopamine in human plasma and its clinical application in patients with chronic kidney disease. Biomedical Chromatography. https://doi.org/10.1002/bmc.5896

Vancouver

Ribeiro LF, Babadopulos T, de Oliveira MG, Nishimaru F, Zatz R, Elias RM, et al. A LC–MS/MS method for the simultaneous determination of 6‐cyanodopamine, 6‐nitrodopamine, 6‐nitrodopa, 6‐nitroadrenaline and 6‐bromodopamine in human plasma and its clinical application in patients with chronic kidney disease. Biomedical Chromatography. 2024. doi:10.1002/bmc.5896

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Luiz Fernando and Babadopulos, Tainah and de Oliveira, Mariana G and Nishimaru, Flávio and Zatz, Roberto and Elias, Rosilene Motta and Moraes, Odorico and Moraes, Elisabete and Peterson, Larryn W and De Nucci, Gilberto},
  title = {A LC–MS/MS method for the simultaneous determination of 6‐cyanodopamine, 6‐nitrodopamine, 6‐nitrodopa, 6‐nitroadrenaline and 6‐bromodopamine in human plasma and its clinical application in patients with chronic kidney disease},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5896}
}
Kostenlos starten →